<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent</th><th>Designation</th><th>Source</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Gene <break/>(human)</td><td>tau RD <break/>(LM)-YFP</td><td>PMID: 24857020</td><td/><td/></tr><tr><td>Cell line <break/>(human)</td><td>DS1; DS9; DS10</td><td>PMID: 24857020</td><td/><td/></tr><tr><td>Cell line <break/>(human)</td><td>Tau RD P301S <break/>FRET Biosensor</td><td>PMID: 25261551, <break/>ATCC</td><td>ATCC CRL-3275, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_DA04">CVCL_DA04</ext-link></td><td/></tr><tr><td>Cell line <break/>(human)</td><td>DS9.1; <break/>DS10.1; <break/>DS10.2; <break/>DS10.3,DS10.4, <break/>AD(t); AD(m); <break/>CBD1(t); CBD2(t); <break/>CBD1(m); CBD2(m); <break/>CBD3(m)</td><td>This paper</td><td/><td>These are cell <break/>lines created <break/>from tau seeds <break/>(total lysate <break/>and/or <break/>seed-competent <break/>monomer) that derived <break/>either from clonal <break/>cell lines DS9 <break/>and DS10, or <break/>Alzheimer&#8217;s or <break/>Corticobasal <break/>Degeneration disease <break/>brain samples <break/>that were inoculated <break/>into DS1 cell lines, <break/>as described in <break/>the Materials and <break/>Methods, and <break/>Results sections.</td></tr><tr><td>Antibody&#160;(rabbit)</td><td>TauA (polyclonal against <break/>QTAP&#8230;KIGSTENL)</td><td>This paper</td><td/><td>Antibodies used <break/>at dilution <break/>indicated in <break/>Materials and <break/>Methods <break/>section (1:1000).</td></tr><tr><td>Antibody&#160;(rabbit)</td><td>Anti-GFP <break/>(polyclonal)</td><td>Rockland Inc.</td><td>Rockland <break/>antibodies: <break/>600-401-215, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_828167">AB_828167</ext-link></td><td>Antibodies used at <break/>dilution indicated <break/>in Materials and <break/>Methods section <break/>(1:1000)</td></tr><tr><td>Antibody&#160;(mouse)</td><td>HJ 9.3 (monoclonal <break/>against tau RD)</td><td valign="bottom">PMID:24075978, <break/>PMID:29566794</td><td valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2721235">AB_2721235</ext-link></td><td>Antibodies used at <break/>dilution indicated <break/>in Materials and <break/>Methods section <break/>(1:2000)</td></tr><tr><td>Antibody&#160;(donkey)</td><td>ECL <break/>Anti-Rabbit</td><td valign="bottom">GE Lifesciences</td><td valign="bottom">NA9340V,</td><td>Antibodies <break/>used at dilution <break/>indicated in <break/>Materials and <break/>Methods <break/>section <break/>(1:2000)</td></tr><tr><td>Antibody&#160;(sheep)</td><td>ECL <break/>Anti-Mouse</td><td valign="bottom">GE <break/>Lifesciences</td><td valign="bottom">NA931V</td><td>Antibodies used at <break/>dilution indicated <break/>in Materials and <break/>Methods section <break/>(1:2000)</td></tr><tr><td>Commercial <break/>assay</td><td>Amersham ECL <break/>Western Blotting <break/>reagent</td><td>GE <break/>Lifesciences</td><td>GE Lifesciences: <break/>RPN2236</td><td/></tr><tr><td>Commercial <break/>assay</td><td>100 kD Spin filter</td><td>Corning <break/>Spin-X UF</td><td>Corning: 431481</td><td/></tr><tr><td>Commercial <break/>assay</td><td>Agarose <break/>beads</td><td>Pierce protein <break/>A/G Plus</td><td>Thermo <break/>fisher: 20423</td><td/></tr><tr><td>Software</td><td>Graphpad <break/>Prism</td><td>Graphpad <break/>software LLC</td><td/><td/></tr><tr><td>Software</td><td>FlowJo</td><td>FlowJo LLC</td><td/><td/></tr><tr><td>Other</td><td>Lipofectamine <break/>2000</td><td>Thermofisher</td><td>Thermo <break/>fisher: 11668019</td><td>transfection <break/>reagent</td></tr></tbody></table></table-wrap>